Meeting NewsVideo

VIDEO: Foundation progresses in fighting inherited retinal diseases

NEWPORT BEACH, Calif. — Jason Menzo, chief operating officer of the Foundation Fighting Blindness, the leading private funder of research for inherited retinal diseases, discusses progress the organization has helped fund, such as the approval of Luxturna (voretigene neparvovec-rzyl, Spark Therapeutics). To find out more about clinical trials ongoing in the inherited retinal disease space, go to www.blindness.org.

NEWPORT BEACH, Calif. — Jason Menzo, chief operating officer of the Foundation Fighting Blindness, the leading private funder of research for inherited retinal diseases, discusses progress the organization has helped fund, such as the approval of Luxturna (voretigene neparvovec-rzyl, Spark Therapeutics). To find out more about clinical trials ongoing in the inherited retinal disease space, go to www.blindness.org.

    See more from OCTANe Ophthalmology Technology Summit